R. Voorzaat

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

L. Kwanten, J. McLellan, P. Rigaux, 2017, Nature Communications.

Stabilizing the closed SARS-CoV-2 spike trimer

L. Renault, J. Juraszek, J. Langedijk, 2020, Nature Communications.

Stabilizing the closed SARS-CoV-2 spike trimer

L. Renault, J. Juraszek, J. Langedijk, 2021, Nature Communications.

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

J. McLellan, P. Rigaux, D. Roymans, 2017, Nature Communications.

Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G

F. Cox, J. Vaneman, Lisanne Tettero, 2024, Vaccines.

Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein

L. van der Fits, J. Juraszek, N. Johnson, 2024, Nature communications.